There was no difference in risk for CV death between the semaglutide and placebo groups (semaglutide, 3.1%
Bonnefoy M, Gilbert T
Q424: Bariatric procedures in the US declined low-to-mid single digit range. Within a year of first mentioning the GLP-1 threat, Intuitives bariatrics franchise went from growing 20%+ growth to negative growth
AMA Biological aging tests, longevity training, emerging therapies, GLP-1 RAs, sun exposure, and more #383 AMA #81: Biological aging tests, longevity training, emerging therapies, GLP-1 RAs, sun exposure, and more In this Ask Me Anything (AMA) episode, Peter answers listener questions that pull back the curtain on how he actually thinks and operates across a wide range of topics in health and longevity
Effects of lauroyl arginate ethyl (LAE) on pathogen inactivation and quality attributes of spinach leaves
Barakat, G